Artículos por temáticas

Unraveling the Gut-Heart Axis: Missing Links in the Brain-First Versus Body-First Hypothesis of Parkinson's Disease

Totsune T, Baba T, Hasegawa T, Takeda A.

Mov Disord. 2025 Aug;40(8):1738-1739. doi: 10.1002/mds.30268. Epub 2025 Jul 7.

Correction: Editorial: 15 years of frontiers in neuroanatomy: the origin of Parkinson's disease

Falquetto B, Nombela C, Britto LRG.

Front Neuroanat. 2025 Jul 28;19:1666562. doi: 10.3389/fnana.2025.1666562. eCollection 2025.

Reduction of Festinating Clinical Gait Parameters to Near Normal After Hip Joint Mobilization: A Parkinson's Disease Case Report

Wong CK, Macpherson CE.

Cureus. 2025 Jul 18;17(7):e88242. doi: 10.7759/cureus.88242. eCollection 2025 Jul.

Using a Back-Worn Accelerometer to Capture Nocturia Frequency in Parkinson's: An Exploratory Study

Cullen A, Smith MD, Henderson EJ.

Neurourol Urodyn. 2025 Aug;44(6):1389-1391. doi: 10.1002/nau.70011. Epub 2025 Feb 17.

Sleep Stage Classification Using Subthalamic Nucleus Local Field Potentials Following Long-Term Neuromodulation in Parkinson's Disease

Zhang G, Guan L, Gao Y, Shi L, Yuan X, Zhang Y, Yin G, Yang A, Meng F, Zhang J, Yu H, Li L.

Mov Disord. 2025 Aug;40(8):1732-1734. doi: 10.1002/mds.30264. Epub 2025 Jun 12.

Correction: The abnormal audiovisual conflict in Parkinson's disease patients is manifestedin perception rather than response

Zhou H, Bao Y, Zou N, Fan G, Sang H, Wang E, Wang A.

Sci Rep. 2025 Jul 7;15(1):24227. doi: 10.1038/s41598-025-09188-4.

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease

Ory-Magne F, Houeto JL, Fabbri M.

Mov Disord Clin Pract. 2025 Jul 24. doi: 10.1002/mdc3.70253. Online ahead of print.

Is Hypomethylation of the α-Synuclein Gene in Parkinson's Disease Patients Related to Chronic Levodopa Intake?

Müller T, Kuhn W.

Mov Disord. 2025 Aug;40(8):1752-1753. doi: 10.1002/mds.30263. Epub 2025 Jun 9.

Levodopa-carbidopa intestinal gel for multiple system atrophy with motor fluctuations: a case series

Iseki T, Nishikawa N, Ogawa T, Oyama G, Nishioka K, Hatano T, Shimo Y, Hattori N.

Ther Adv Neurol Disord. 2025 Aug 8;18:17562864251360048. doi: 10.1177/17562864251360048. eCollection 2025.

Correction: The Role of Alpha-Synuclein and Tubulin-Associated Unit (Tau) Proteins in the Diagnosis, Prognosis, and Treatment of Parkinson's Disease: A Systematic Review

Lin YM, Banoth D, Wali MH, Bekova K, Abdulla N, Gurugubelli S, Khan S.

Cureus. 2025 Aug 24;17(8):c253. doi: 10.7759/cureus.c253. eCollection 2025 Aug.

The effects of stretching in Parkinson's disease: A systematic review of randomized controlled trials

Duñabeitia I, González-Devesa D, Blanco-Martínez N, Ayán-Pérez C.

Parkinsonism Relat Disord. 2025 Jul;136:107865. doi: 10.1016/j.parkreldis.2025.107865. Epub 2025 May 17.

Stress Hyperglycemia Ratio as a Predictor of Parkinson's Disease: Statistical Caveats Matter

Li S, Chen X.

Eur J Neurol. 2025 Aug;32(8):e70333. doi: 10.1111/ene.70333.

Rhythmic Eyelid Closure Responsive to STN-DBS: Blepharoclonus, Blepharospasm, Eyelid Opening Apraxia, or Eyelid Tremor?

Gaudiano G, Boogers A, Grippe T, Cilia R, Eleopra R, Chen R, Fasano A.

Mov Disord Clin Pract. 2025 Jul;12(7):1020-1023. doi: 10.1002/mdc3.70030. Epub 2025 Mar 11.

Therapeutic Potential of Sea Cucumber-Derived Bioactives in the Prevention and Management of Brain-Related Disorders: A Comprehensive Review

Debi PR, Barua H, Ahmmed MK, Bhowmik S.

Mar Drugs. 2025 Jul 30;23(8):310. doi: 10.3390/md23080310.

Fixing a Shaky Video to Remotely Program Deep Brain Stimulation

Justich MB, Boogers A, Lozano AM, Fasano A.

Tremor Other Hyperkinet Mov (N Y). 2025 Jul 28;15:33. doi: 10.5334/tohm.963. eCollection 2025.